Cite
HARVARD Citation
Bakou, V. et al. (n.d.). Augmented apoptotic efficacy of brentuximab vedotin combined with lenalidomide in CD-30 expressing Sézary syndrome cell lines. European journal of cancer. pp. S18-S19. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bakou, V. et al. (n.d.). Augmented apoptotic efficacy of brentuximab vedotin combined with lenalidomide in CD-30 expressing Sézary syndrome cell lines. European journal of cancer. pp. S18-S19. [Online].